Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma
Clinical trial NCT06141109 · UNKNOWN
Trial details
- NCT number
- NCT06141109
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-18
- Primary completion
- 2024-07-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.